Jack Wallace
Stock Analyst at Guggenheim
(2.24)
# 1,464
Out of 4,412 analysts
22
Total ratings
47.37%
Success rate
-2.3%
Average return
Main Sectors:
9 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCM R1 RCM | Maintains: Buy | $17 → $15 | $11.90 | +26.05% | 4 | Apr 5, 2024 | |
| WW WW International | Reiterates: Buy | $12 | $1.75 | +585.71% | 2 | Mar 18, 2024 | |
| HIMS Hims & Hers Health | Maintains: Buy | $15 → $17 | $12.50 | +36.00% | 4 | Feb 27, 2024 | |
| HCAT Health Catalyst | Upgrades: Buy | $14 | $6.03 | +132.17% | 3 | Jan 26, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $253 → $220 | $234.88 | -6.34% | 1 | Nov 3, 2023 | |
| VEEV Veeva Systems | Upgrades: Buy | $226 | $200.91 | +12.49% | 2 | Jun 1, 2023 | |
| PHR Phreesia | Maintains: Buy | $35 → $40 | $20.61 | +94.08% | 4 | Mar 29, 2023 | |
| AMWL American Well | Reiterates: Buy | $5 | $0.53 | +846.97% | 1 | Mar 15, 2023 | |
| PINC Premier | Initiates: Neutral | n/a | $20.96 | - | 1 | Apr 14, 2022 |
R1 RCM
Apr 5, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $11.90
Upside: +26.05%
WW International
Mar 18, 2024
Reiterates: Buy
Price Target: $12
Current: $1.75
Upside: +585.71%
Hims & Hers Health
Feb 27, 2024
Maintains: Buy
Price Target: $15 → $17
Current: $12.50
Upside: +36.00%
Health Catalyst
Jan 26, 2024
Upgrades: Buy
Price Target: $14
Current: $6.03
Upside: +132.17%
IQVIA Holdings
Nov 3, 2023
Maintains: Buy
Price Target: $253 → $220
Current: $234.88
Upside: -6.34%
Veeva Systems
Jun 1, 2023
Upgrades: Buy
Price Target: $226
Current: $200.91
Upside: +12.49%
Phreesia
Mar 29, 2023
Maintains: Buy
Price Target: $35 → $40
Current: $20.61
Upside: +94.08%
American Well
Mar 15, 2023
Reiterates: Buy
Price Target: $5
Current: $0.53
Upside: +846.97%
Premier
Apr 14, 2022
Initiates: Neutral
Price Target: n/a
Current: $20.96
Upside: -